53179-12-7|Clopimozide|1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-5-chloro-1,3-dihydro-2H-benzo[d]imidazol-2-one|-范德生物科技公司

Clopimozide

NMR下载 COA and HPLC MSDS下载
names：
1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-5-chloro-1,3-dihydro-2H-benzo[d]imidazol-2-one
CAS号：
53179-12-7
MDL Number：
MF(分子式)： C28H28ClF2N3O MW(分子量)： 495.99
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Clopimozide
英文别名	Clopimozide; NSC 335305; NSC-335305; NSC335305; R 29764; R-29764; R29764;
CAS号	53179-12-7
Inchi	InChI=1S/C28H28ClF2N3O/c29-21-7-12-27-26(18-21)32-28(35)34(27)24-13-16-33(17-14-24)15-1-2-25(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24-25H,1-2,13-17H2,(H,32,35)
InchiKey	JCZYXTVBWHAWLL-UHFFFAOYSA-N
分子式 Formula	C28H28ClF2N3O
分子量 Molecular Weight	495.99
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Clopimozide(CAS:53179-12-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Clopimozide is a diphenylbutylpiperidine neuroleptic. Its action is mainly ataraxic but also antidelusional, long-acting and accompanied with minimal side-effects.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]De Cuyper HJ, Van Praag HM, Mulder WR. Therapeutical significance of clopimozide in the treatment of chronic psychotic patients. Acta Psychiatr Scand. 1979 May;59(5):561-74. PubMed PMID: 37697.

[2]Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Wauquier A. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series. Arzneimittelforschung. 1975 Aug;25(8):1287-94. PubMed PMID: 1242360.

[3] Floru L, Tegeler J. Clinical experiments with the new oral long-acting neuroleptic clopimozide (R 29 764). Arzneimittelforschung. 1978;28(2):341-4. PubMed PMID: 25071.

[4] Knapen J, Bollen J, Brugmanns J, Rombaut N. [Treatment of chronic psychoses with oral clopimozide]. Acta Psychiatr Belg. 1976 Jul-Aug;76(4):644-57. French. PubMed PMID: 798469.

[5] Bobon J, Parent M, Toussaint C, Pinchard A. [Long-acting neuroleptics. IV. Preliminary study of clopimozide (R 29764)]. Acta Psychiatr Belg. 1976 Jan-Feb;76(1):138-43. French. PubMed PMID: 970182.

6: Gould RJ, Murphy KM, Reynolds IJ, Snyder SH. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc Natl Acad Sci U S A. 1983 Aug;80(16):5122-5. PubMed PMID: 6136040; PubMed Central PMCID: PMC384201.7: Mixon T, Fitzsimmons P. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results. J Invasive Cardiol. 2006 Jun;18(6):E166-8. PubMed PMID: 16775892.8: Qar J, Galizzi JP, Fosset M, Lazdunski M. Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade. Eur J Pharmacol. 1987 Sep 11;141(2):261-8. PubMed PMID: 2445589.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开